Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial

201075 citationsJournal Article

Authors

Good health and well-being

Published in: The Lancet Neurology

Volume 9, Issue 7, pp. 672-680

Field-Weighted Citation Impact: 6.73